913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Since the second quarter, the enthusiasm of public funds for investigating a shares has risen steadily. Data show that since the second quarter, 913 A-share listed companies have been investigated by public funds. Among them, 84 companies were investigated by 50 or more public funds; Goer shares, Qiaqia food, Mindray medical, Ziguang Guowei, Junshi biology, Lizhong group and other six companies have received intensive research from more than 100 public funds. Hu Bo, the manager of Rongzhi investment fund under paipai.com, said, "new energy, science and technology and other tracks that maintain a high landscape are still the main direction of China's economic development and the focus of industrial upgrading in the future. Most enterprises are growing enterprises. After full adjustment in the early stage, the investment value has gradually appeared, which has attracted many public funds to gather for research".
This text is a result of machine translation.
Related companies：
Briefing Jun 27, 2022 02:19 PM
· Technology
Special representative of the Russian President: Russia will realize technological sovereignty within 10 to 20 years
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Briefing Jun 22, 2022 11:50 AM
Three departments: incorporate the construction of public fitness facilities in rural areas into the five-year action plan for building fitness facilities in various regions
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Jun 29, 2021 11:48 PM
May 03, 2021 09:18 AM
Briefing Jun 22, 2022 10:50 AM
Goethe shares flash crash limit Securities Department: the company's operation is stable, and the expectation for the second quarter has not been adjusted
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
Briefing Jun 01, 2022 09:23 AM
· Financials
American officials: the United States plans to expand its diplomatic presence in the Indian Pacific Region
Briefing May 24, 2022 02:24 PM
· Healthcare
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
Healthcare
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
See more
Read next
Insight
In-depth
Automotive · Analysis
Shanghai and Shenzhen: The Dual-City Landscape and Corporate Power
Jan 09, 2025 03:35 PM
Insight
In-depth
Technology, Healthcare · Interview
Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain"
Jan 08, 2025 06:10 PM
Insight
In-depth
Automotive, Technology · Interview
How AI is Driving Globalization and Transformation in Emerging Industries? | Highlights
Jan 08, 2025 05:44 PM
Insight
In-depth
Consumer Staples, Communication · Interview
How Can F&B and Retail Companies Effectively Replicate Local Success Models? | Highlights
Jan 08, 2025 05:09 PM